N/A
N=23
Continuous Glucose Monitoring in Prediabetes
Pre-diabetes
Bottom Line
View on ClinicalTrials.gov: NCT06472297 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Change in Mean Glucose (mg/dL) From Baseline — 2.1 mg/dL — p=0.8
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- The continuous glucose monitoring system (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Southern California
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean Glucose (mg/dL) From Baseline |
2.1 | 0.8 |
Summary
The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.
Eligibility Criteria
Inclusion Criteria
- Prediabetes by finger prick blood A1C%
- Centers for Disease Control and Prevention (CDC) prediabetes risk test score of 5 or higher
- Willingness to wear CGM sensor
- Latino community health worker
Exclusion Criteria
- Currently pregnant
- Less than 18 years of age, which is adult in California
- Diagnosed with any disorder that interferes with glucose
- Influential medical disorder/event affecting ability to participate in study
- Incompatible smartphone device not pairing with Dexcom G6 app
Data sourced from ClinicalTrials.gov (NCT06472297). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.